Elevated Monocytes and Eosinophils
Elevated eosinophils are clinically significant because eosinophil-driven disorders can cause tissue damage and organ dysfunction in hypereosinophilic syndrome (HES) variants. [1]
Elevated monocytes are clinically significant because monocytosis can occur in myeloid neoplasms and immune dysregulation syndromes, including chronic myelomonocytic leukemia (CMML)–spectrum disorders and Ras-associated autoimmune leukoproliferative disorder (RALD). [2,3]
Elevated Eosinophils: Clinical Significance
Hypereosinophilic syndrome (HES) is characterized by eosinophil-driven tissue damage and dysfunction. [1]
HES variants commonly involve the heart, lungs, skin, liver, spleen, and lymph nodes. [1]
Corticosteroids are commonly used in idiopathic HES and lymphocytic HES, while imatinib is commonly used in myeloproliferative HES variants. [1]
Elevated Eosinophils: Common Clinical Contexts
Eosinophilia is relevant in eosinophil-mediated inflammatory phenotypes across organ systems. [1]
Eosinophilic endotypes can mark inflammatory biology linked to disease expression in chronic airway disorders, including eosinophilic COPD phenotypes. [4]
Elevated Monocytes: Clinical Significance
Monocytosis can be a feature of RALD, which includes splenomegaly, autoimmune cytopenias, and monocytosis among its common findings. [3]
Monocytosis can be observed in myeloid neoplasms at the CMML–primary myelofibrosis with monocytosis intersection, where monocytosis coexists with myeloid disorders and fibrosis. [2]
Elevated Monocytes and Eosinophils: Shared Clinical Implications
Marked or persistent elevations of either lineage warrant evaluation for hematologic and inflammatory etiologies that can involve multiple organ systems. [1,2,3]
Evaluation Priorities
The evaluation priority for eosinophilia includes assessment for HES phenotypes because HES involves eosinophil-driven organ involvement and dysfunction. [1]
The evaluation priority for monocytosis includes assessment for myeloid neoplasms and immune dysregulation syndromes, including CMML-spectrum conditions and RALD, because both can present with monocytosis. [2,3]
Common Pitfalls to Avoid
Attributing eosinophilia solely to benign causes without assessment for HES-spectrum organ involvement risks missing eosinophil-driven tissue damage syndromes. [1]
Attributing monocytosis solely to transient infection or inflammation risks missing myeloid neoplasms and immune dysregulation disorders that can present with persistent monocytosis. [2,3]
When Urgent Assessment Is Indicated
Urgent assessment is indicated when eosinophilia is accompanied by signs or symptoms of organ dysfunction consistent with HES involvement patterns. [1]
Urgent assessment is indicated when monocytosis is accompanied by features suggesting a myeloid neoplasm or severe systemic illness that can occur in CMML-spectrum and RALD presentations. [2,3]